215 related articles for article (PubMed ID: 11584358)
1. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
[TBL] [Abstract][Full Text] [Related]
2. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
3. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
[TBL] [Abstract][Full Text] [Related]
4. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction.
Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K
Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase 2 in human malignant melanoma.
Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in the gallbladder of patients with anomalous arrangement of the pancreaticobiliary duct.
Fumino S; Tokiwa K; Ono S; Iwai N
J Pediatr Surg; 2003 Apr; 38(4):585-9. PubMed ID: 12677571
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J
Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821
[TBL] [Abstract][Full Text] [Related]
8. The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells.
Grossman EM; Longo WE; Panesar N; Mazuski JE; Kaminski DL
Carcinogenesis; 2000 Jul; 21(7):1403-9. PubMed ID: 10874020
[TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of expression of cyclooxygenase-2 gene in breast cancer].
Guo GL; Yao ZX; Wu J
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1661-4. PubMed ID: 14642098
[TBL] [Abstract][Full Text] [Related]
10. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
[TBL] [Abstract][Full Text] [Related]
14. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
[TBL] [Abstract][Full Text] [Related]
15. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
[TBL] [Abstract][Full Text] [Related]
16. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
19. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
20. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
